UnknownPhase 4NCT01111981

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Callender Center for Clinical Research
Principal Investigator
Valerie Callender, M.D., MD
Callender Skin for Clinical Research
Intervention
Clobetasol Propionate 0.05% Emollient Foam(drug)
Enrollment
30 target
Eligibility
18-80 years · FEMALE
Timeline
20092010

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01111981 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials